The U.S. Food and Drug Administration has permitted marketing of the Philips IntelliSite Pathology Solution (PIPS, Philips Medical Systems Nederland B.V.), as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue.

PIPS is an automated digital slide creation, viewing, and management system that will allow pathologists to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue, rather than having to look directly under a conventional light microscope at a tissue sample mounted on a glass slide. This is the first FDA-authorized digital pathology whole slide imaging (WSI) system available for these purposes.

  more...
The U.S. Food and Drug Administration has approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in people 18 through 65 years of age.

“House dust mite allergic disease can negatively impact a person’s quality of life,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “The approval of Odactra provides patients an alternative treatment to allergy shots to help address their symptoms.”

  more...
The U.S. Food and Drug Administration has approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

VWD is the most common inherited bleeding disorder, affecting approximately 1 percent of the U.S. population. Men and women are equally affected by VWD, which is caused by a deficiency or defect in von Willebrand factor, a protein that is critical for normal blood clotting. Patients with VWD can develop severe bleeding from the nose, gums, and intestines, as well as into muscles and joints. Women with VWD may have heavy menstrual periods lasting longer than average and may experience excessive bleeding after childbirth.

  more...
The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach.

Ivax Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceuticals USA, has gained approval to market esomeprazole in 20 and 40 milligram capsules.

  more...
LV8702V is optimized to reduce motor noise, vibration and heat generation, and deliver no-load power consumption savings of up to 80 percent *1

High-Efficiency Stepper Motor Driver

PHOENIX, Ariz. ON Semiconductor Nasdaq: ONNN),driving innovation in energy efficiency, has introduced the LV8702V, a new stepper motor driver IC that delivers significantly improved efficiency versus existing products on the market. The device has been specifically designed for office automation equipment applications such as copiers, scanners and multi-function printers.

  more...
Newest FS Series 3 Module is Latest Milestone on Cost-Efficiency Roadmap

TEMPE, Ariz.--(BUSINESS WIRE)-- First Solar, Inc. (Nasdaq: FSLR) has released of its most advanced thin-film photovoltaic (PV) module, the Series 3 FS-392, which is rated at 92.5 watts. The new FS-392 module maintains all the existing IEC certifications and UL listings for the Series 3 family, including UL listing for 1000-volt systems.

  more...
Search News

Arizona Free Press

Contact us by email.

Physical Address

550 N. Willow St.
Globe, AZ 85501

Mailing Address

550 N. Willow St.
Globe, AZ 85501